Brief: TetraLogic announces update on MDS clinical program

Tetralogic Pharmaceuticals

30/06/2015 21:01

June 30 (Reuters) - TetraLogic Pharmaceuticals Corp  TLOG.O : 
 * Announces update on mds clinical program 
 * Preliminary data from phase 2a study of birinapant in combination with 
   azacitidine 
 * Says study is being conducted as a precursor to the ongoing randomized phase 
   2b study. 
 * Says nine patients who entered study, six completed four cycles of therapy 
   and underwent a repeat bone marrow assessment 
 
 * Source text for Eikon  ID:nGNXVDXIOa  
 * Further company coverage  TLOG.O   
 
((Bengaluru Newsroom; +1 646 223 8780))